Net loss of Sarda Proteins reported to Rs 0.12 crore in the quarter ended December 2025 as against net profit of Rs 0.10 crore during the previous quarter ended December 2024. Sales declined 98.96% to Rs 0.25 crore in the quarter ended December 2025 as against Rs 24.05 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.2524.05 -99 OPM %-48.000.42 - PBDT-0.120.10 PL PBT-0.120.10 PL NP-0.120.10 PL Powered by Capital Market - Live News

Sarda Proteins will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live News

Net profit of Sarda Proteins rose 263.64% to Rs 0.40 crore in the quarter ended September 2025 as against Rs 0.11 crore during the previous quarter ended September 2024. Sales rose 2971.43% to Rs 4.30 crore in the quarter ended September 2025 as against Rs 0.14 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales4.300.14 2971 OPM %6.7478.57 - PBDT0.400.11 264 PBT0.400.11 264 NP0.400.11 264 Powered by Capital Market - Live News

Sarda Proteins has adjourned the meeting of the Board of Directors which was scheduled to be held on 26 November 2025. The meeting will now be held on 29 November 2025.Powered by Capital Market - Live News

Sarda Proteins will hold a meeting of the Board of Directors of the Company on 26 November 2025.Powered by Capital Market - Live News